We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Nuclera

Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science researchers with easy access to target proteins.

Latest Content

Scientist analyzing microscopic images on a computer in a modern laboratory.

New Alliance Speeds Membrane Protein Discovery

Nuclera and leadXpro announced a partnership combining cell-free multiplex membrane protein screening with AI and structural biology expertise.

3D illustration of spherical protein molecules with surface structures in a biological environment.

Nuclera raises $12M To expand AI-powered protein platform

Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody expression, purification, and binding validation, enabling scalable, AI-driven biologics research.

Modern laboratory setup with microscopes and data screens used in protein discovery research.

Nuclera Expands eProtein Discovery Into Asia

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University and National Cheng Kung University.

3D molecular visualization of a protein structure. The background is green and there is an assortment of red, yellow, blue and pink ball and stick molecules.

Industry Insight

Advancing Membrane Protein Research With Cell-Free Expression Systems

At the recent ELRIG Drug Discovery conference, Technology Networks spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

Scientist analyzing test tubes in a lab, representing Nuclera’s eProtein Discovery expansion in the APAC region.

Nuclera Expands eProtein Discovery Access in APAC Region

Nuclera partners with Solve Scientific to expand eProtein Discovery access across Australia, New Zealand and APAC markets.

Front cover of a Cytiva and Nuclera application note on accelerated kinase drug discovery workflow.

App Note / Case Study

Speed Up Kinase Drug Target Characterization

This application note presents a next-generation approach to drug discovery - combining AI-guided structural design with rapid, automated digital microfluidics-based screening workflows that optimize protein expression. Researchers can obtain purifi

3D illustration of a protein structure with complex molecular chains and atomic bonds in blue and red hues, representing molecular biology and biochemistry.

Nuclera and Cytiva Collaborate To Accelerate Characterization of Proteins for Drug Development

Nuclera and Cytiva collaborate to speed protein production and characterization, accelerating drug development workflows.

eProtein Discovery™ system by Nuclea for membrane protein workflow automation.

Nuclera Expands eProtein Discovery Capabilities To Enable Membrane Protein Production

Nuclera has enhanced its eProtein Discovery™ system with a new membrane protein workflow, offering rapid expression, purification, and stabilization of membrane proteins.

A vibrant 3D illustration of a protein molecule with intertwined structures in green, orange, and purple against a dark background.

Industry Insight

Advancing Protein Prototyping Through Rapid and Efficient Systems

In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.

Abstract depiction of a cancer cell targeted by glowing neon crosshairs, symbolizing drug targeting

Accelerating Drug Target Identification and Characterization

This webinar highlights how a streamlined workflow combining recombinant protein expression and interaction analysis accelerates drug–target screening, scaling, and characterization, improving efficiency and enabling faster decisions in drug discover

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter